Women considering surgery to receive breast implants should be warned in advance of the risk of serious complications, including fatigue, joint pain and the possibility of a rare type of cancer, the Food and Drug Administration said on Wednesday. It will be left to doctors to review those risks with women seeking breast implants. The measures are not mandated by the agency; they are proposals now open to public comment and industry input. Advocates for women with complications linked to breast implants called the F.D.A.’s proposals “an important step,” but noted that the action is only a recommendation. “What matters most is what happens next,” said Diana Zuckerman, president of the National Center for Health Research in Washington, who has analyzed breast implant studies and has been advising patients.

Source: New York Times October 23, 2019 13:04 UTC